Lucy Day
Chief Financial Officer, AN2 Therapeutics, Inc.
Companies
- AN2 Therapeutics, Inc.Chief financial officer Mar 24, 2022 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- AN2 Therapeutics, Inc. ANTX118,363 shares2$387.0K at $3.27Feb 20, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 20, 2026Granted 38,000 shares of AN2 Therapeutics, Inc.2
- Jan 6, 2026Sold 5,512 shares at $1.01 of AN2 Therapeutics, Inc.3
- Jan 5, 2026Sold 3,295 shares at $1.00 of AN2 Therapeutics, Inc.3
- Feb 26, 2025Granted 46,500 shares of AN2 Therapeutics, Inc.4
- Jan 3, 2025Sold 2,957 shares at $1.34 of AN2 Therapeutics, Inc.5
- Mar 15, 2024Granted 27,500 shares of AN2 Therapeutics, Inc.6
- Mar 15, 2024Granted 27,500 shares of AN2 Therapeutics, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jan 7, 2026
- 4SEC EDGARForm 4 filed Feb 28, 2025
- 5SEC EDGARForm 4 filed Jan 7, 2025
- 6SEC EDGARForm 4 filed Mar 29, 2024
- 7SEC EDGARForm 4 filed Mar 18, 2024